Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cenegermin in Neurotrophic Keratitis
NCT02227147Phase 2Completed
- Sponsor
- Dompé
- Start
- Feb 2015
- Primary completion
- Jun 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of cenegermin in neurotrophic keratitis (NK), sponsored by Dompé. Started Feb 2015; status: completed.
02
Drugs
cenegermin
03
Conditions
neurotrophic keratitis (NK)
Beyond the preview
Go deeper on NCT02227147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02227147.